Shuai Wang Tri lab’s Website
Our laboratory, located in Dalian, China, investigates the mechanisms underlying retinal vascular dysfunction and ocular surface disease, with a focus on inflammation, oxidative stress, and translational therapeutic strategies. We aim to understand how cellular stress responses and intercellular signaling drive tissue degeneration and barrier breakdown, and how these processes can be therapeutically targeted. We welcome academic and clinical collaborations.
Highlights
Our Research
Retinal vascular disease and gene therapy
We study the mechanisms by which inflammation and oxidative stress disrupt retinal and choroidal microvascular integrity in age-related and injury-induced retinal diseases. Using in vivo disease models and AAV-based gene therapy approaches, our work aims to identify protective pathways and secreted factors that stabilize the neurovascular unit and preserve retinal function
Our Projects
Dry eye disease: mechanisms and biomaterial-based translational strategies
We investigate the pathophysiology of dry eye disease, with an emphasis on ocular surface inflammation, epithelial stress responses, and tissue homeostasis. In parallel, we develop and translate biomaterial-based therapeutic platforms designed to improve ocular surface protection and long-term treatment efficacy.
Our Team
We possess a dynamic and well-structured talent pool, where team members combine profound clinical expertise with rigorous scientific training, actively engaging in graduate education and teaching reform.